Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: An endoscopic study in monkeys

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 5, 2006, Pages 442-446

  Fisch, Cecile ^a   Attia, Mahmoud ^a   Dargent, François ^a   De Jouffrey, Stéphane ^a   Dupin Roger, Isabelle ^b   Claude, Jean Roger ^c  

^a CIT   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STRONTIUM RANELATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EROSION; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS INJURY; ESOPHAGUS ULCER; EVALUATION; FEMALE; GASTROSCOPY; GRANULOCYTE; MACACA; MALE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH EROSION; STOMACH LESION; STOMACH MUCOSA; STOMACH ULCER; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; BIOPSY; DRUG EVALUATION, PRECLINICAL; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGOSCOPY; ESOPHAGUS; MACACA FASCICULARIS; MODELS, ANIMAL; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; STOMACH; STRONTIUM; THIOPHENES; TIME FACTORS;

ANIMALIA; MACACA; MACACA FASCICULARIS;

EID: 33646262863     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_269.x     Document Type: Article

References (25)

1. Barkin J. S. A. M. Harary C. E. Shamblen K. C. Lasseter Potassium chloride and gastrointestinal injury Ann. Intern. Med. 1983 98 261 262
2. Baron R. Y. Tsouderos In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur. J. Pharmacol. 2002 450 11 17
3. Black D. M. S. R. Cummings D. B. Karpf J. A. Cauley D. E. Thompson M. C. Nevitt D. C. Bauer H. K. Genant W. L. Haskell R. Marcus S. M. Ott J. C. Torner S. A, Quandt T. F. Reiss K. E. Ensrud Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 1996 348 1535 1541
4. Canalis E. M. Hott P. Deloffre Y. Tsouderos P. J. Marie The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone 1996 18 517 523
5. Cummings S. R. D. M. Black D. E. Thompson W. B. Applegate E. Barrett-Connor T. A. Musliner L. Palermo R. Prineas S. M. Rubin J. C. Scott T. Vogt R. Wallace A. J. Yates A. Z. LaCroix Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures J. Amer. Med. Ass. 1998 280 2077 2082
6. de Groen P. C. D. F. Lubbe L. J. Hirsch A. Daifotis W. Stephenson D. Freedholm S. Pryor-Tillotson M. J. Seleznick H. Pinkas K. K. Wang Esophagitis associated with the use of alendronate New Engl. J. Med. 1996 335 1016 1021
7. Dubois A. D. E. Berg E. T. Incecik N. Fiala L. M. Heman-Ackah G. I. Perez-Perez M. J. Blaser Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease Infect. Immun. 1996 64 2885 2891
8. Euler A. R. G. E. Zurenko J. B. Moe R. G. Ulrich Y. Yagi Evaluation of two monkey species (Macaca mulatta and Macaca fascicularis) as possible models for human Helicobacter pylori disease J. Clin. Microbiol. 1990 28 2285 2290
9. Graham D. Y. H. M. Malaty R. Goodgame Primary amino-bisphosphonates: a new class of gastrotoxic drugs-comparison of alendronate and aspirin Amer. J. Gastroenterol. 1997 92 1322 1325
10. Graham D. Y. J. L. Smith R. D. Jones A. Rakhit V. Tipnis M. E. Hurley Gastroscopic localization of a microencapsulated KCl preparation in the human stomach Gastrointest. Endosc. 1987 33 220 223
11. Hamilton B. K. McCoy H. Taggart Tolerability and compliance with risedronate in clinical practice Osteoporos. Int. 2003 14 259 262
12. Maconi G. G. B. Porro Multiple ulcerative esophagitis caused by alendronate Amer. J. Gastroenterol. 1995 90 1889 1890
13. Marie P. J. M. Hott D. Modrowski C. De Pollak J. Guillemain P. Deloffre Y. Tsouderos An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J. Bone Miner. Res. 1993 8 607 615
14. McMahon F. G. J. R. Ryan K. Akdamar A. Ertan Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial Lancet 1982 2 1059 1061
15. McMahon F. G. J. R. Ryan K. Akdamar A. Ertan Effect of potassium chloride supplements on upper gastrointestinal mucosa Clin. Pharmacol. Therap. 1984 35 852 855
16. Meunier P. J. P. Marquis E. M. Lemmel T. J. Martin A. Sawicki G. Isaia C. Benhamou M. Walravens H. Beck-Nielsen M. Diaz Curiel E. Seeman J. Y. Reginster Early effect of strontium ranelate on clinical vertebral fractures in women with postmenopausal osteoporosis Bone 2003 32 S222 (abstract)
17. Meunier P. J. C. Roux S. Ortolani J. E. Badurski J. M. Kaufman T. D. Spector A. Diez-Perez E. Seeman E. M. Lemmel A. Balogh S. Pors-Nielsen C. Phenekos R. Rizzoli D. O. Slosman I. Tupinon-Mathieu J. Y. Reginster Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis Osteoporos. Int. 2002a 13 O45 (abstract)
18. Meunier P. J. D. O. Slosman P. D. Delmas J. L. Sebert M. L. Brandi C. Albanese R. Lorenc S. Pors-Nielsen M. C. De Vernejoul A. Roces J. Y. Reginster Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial J. Clin. Endocrinol. Metab. 2002b 87 2060 2066
19. Nobuhara Y. K. Takeuchi Possible role of endogenous prostaglandins in alkaline response in rat gastric mucosa damaged by hypertonic NaCl Dig. Dis. Sci. 1984 29 1142 1147
20. Reginster J. Y. R. Deroisy M. Dougados I. Jupsin J. Colette C. Roux Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial Osteoporos. Int. 2002 13 925 931
21. Reginster J. Y. K. Hoszowski A. Roces Varela A. Balogh M. Clements C. Flore C. Cormier W. E. Schmidt J. B. Jensen R. Prince F. Raeman R. Rizzoli P. J. Meunier Strontium ranelate: a new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in post menopausal osteoporosis Bone 2003 32 S94 (abstract)
22. Reginster J. Y. C. Roux I. Jupsin I. Tupinon-Mathieu Y. Tsouderos Safety of strontium ranelate in prevention of postmenopausal bone loss a double-blind, prospective, placebo controlled study J. Bone Miner. Res. 1999 14 412 (abstract)
23. Sherman A. E. J. Bini Pill-induced gastric injury Amer. J. Gastroenterol. 1999 94 511 513
24. Takahashi N. T. Sasaki Y. Tsouderos T. Suda S 12911-2 inhibits osteoclastic bone resorption in vitro J. Bone Miner. Res. 2003 18 1082 1087
25. Takeuchi K. H. Yamakuni Y. Nobuhara S. Okabe Functional and morphological alterations in the rat stomach following exposure to hypertonic NaCl solution Jap. J. Pharmacol. 1986 42 549 560